Market Overview

UPDATE: Sterne Agee Downgrades DSW on Fair Valuation

Share:

In a report published Monday, Sterne Agee analyst Sam Poser downgraded DSW (NYSE: DSW) from Buy to Neutral, and removed the $80.00 price target.

In the report, Sterne Agee noted, “The stock is fairly priced and is trading at our previous price target of $80. Current trends continue to be robust and management is making the right moves. Strong business model, system enhancements and acceleration of EPS growth in 2014 are baked into current multiples.”

DSW closed on Friday at $78.98.

Latest Ratings for DSW

DateFirmActionFromTo
Dec 2018MaintainsNeutralNeutral
Dec 2018MaintainsHoldHold
Dec 2018MaintainsNeutralNeutral

View More Analyst Ratings for DSW
View the Latest Analyst Ratings

Posted-In: Sam Poser Sterne AgeeAnalyst Color Downgrades Analyst Ratings

 

Related Articles (DSW)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
IINDoughertyAssumes34.0
PNRJefferiesInitiates Coverage On
YYUBSUpgrades
ROKUOppenheimerMaintains155.0
IPHIBank of AmericaMaintains80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: J.P. Morgan Initiates bluebird bio at Overweight on Unique & Necessary Medical Products

UPDATE: Sterne Agee Downgrades Genesco on Valuation